EDDM3A drives gastric cancer progression by promoting HIF-1α-dependent aerobic glycolysis
Open Access
- 17 January 2022
- journal article
- research article
- Published by Springer Nature in Oncogenesis
- Vol. 11 (1) , 1-11
Abstract
Epididymal protein 3A (EDDM3A) is a protein involved in sperm maturation. It has been demonstrated that EDDM3A expression is upregulated and promotes cell proliferation in non-small cell lung cancer (NSCLC). However, the role of EDDM3A in other types of human cancers, including gastric cancer (GC), is still unexplored. Here, we show that the expression of EDDM3A is significantly upregulated in gastric cancer (GC) tissues and its upregulation correlates with poorer survival in patients with gastric cancer. Knockdown of EDDM3A inhibited growth and metastasis of GC cells, whereas overexpression of EDDM3A exhibited the opposite effect. Mechanistically, enhanced aerobic glycolysis mediated by upregulation of HIF-1α and subsequently increased target glycolytic genes and decreased mitochondrial biogenesis was found to contribute to the promotion of tumor growth and metastasis by EDDM3A in GC cells. Additionally, upregulation of EDDM3A in GC is at least partially mediated by downregulation of miR-618. In conclusion, elevated EDDM3A plays a pivotal oncogenic role in gastric carcinogenesis, suggesting it as a potential therapeutic target for treatment of GC.Keywords
Funding Information
- National Natural Science Foundation of China (82072722)
This publication has 20 references indexed in Scilit:
- miR‐618 Suppresses Metastasis in Gastric Cancer by Downregulating the Expression of TGF‐β2The Anatomical Record, 2019
- miR-618: possible control over TIMP-1 and its expression in localized prostate cancerBMC Cancer, 2018
- VHL and Hypoxia Signaling: Beyond HIF in CancerBiomedicines, 2018
- Mitochondrial metabolism and cancerCell Research, 2017
- miR-618 Inhibits Prostate Cancer Migration and Invasion by Targeting FOXP2Journal of Cancer, 2017
- HIF-1α pathway: role, regulation and intervention for cancer therapyActa Pharmaceutica Sinica B, 2015
- MiR-618 inhibits anaplastic thyroid cancer by repressing XIAP in one ATC cell lineAnnales d'Endocrinologie, 2014
- NAViGaTing the Micronome – Using Multiple MicroRNA Prediction Databases to Identify Signalling Pathway-Associated MicroRNAsPLOS ONE, 2011
- The VHL Tumor Suppressor: Master Regulator of HIFCurrent Pharmaceutical Design, 2009
- Complete sequencing and characterization of 21,243 full-length human cDNAsNature Genetics, 2003